Search | Page 17 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Amer Zeidan, M.D.

    ... area is the development of novel therapies for MDS and refractory myeloid malignancies with a focus on immune therapy including ...

    Bio last updated 03/11/2016 - 1:41pm.

  2. Phoenix Ho, MD

    ... (MDS), and childhood leukemia, including relapsed and refractory disease Clinical Interests: Inherited Bone Marrow ...

    Bio last updated 03/11/2016 - 1:41pm.

  3. Myelodysplastic Syndromes and autoimmune disorders: Cause or consequence?

    ... neutrophilic dermatosis. Vasculitis is most common in refractory anemia with excess blasts (RAEB) and chronic ...

    Research Review last updated 05/02/2016 - 9:18am.

  4. Eltrombopag now an approved therapy for certain patients with severe aplastic anemia

    ... ATG, and it is the first drug ever approved to treat refractory aplastic anemia. Once a day treatment with this oral, ... FDA has approved eltrombopag for the treatment of these refractory patients.  It is important to note that this new labeling ...

    Page last updated 08/27/2014 - 2:19pm.

  5. Eltrombopag: Recent Discoveries on Potential New Applications for Aplastic Anemia

    ... rounds of immunosuppressive therapy. This is known as refractory SAA. When tested in this setting, it was found to not only ... because there are few therapies available to patients with refractory aplastic anemia.  Additionally, we thought it would be likely that ...

    Interview last updated 02/14/2014 - 2:01pm.

  6. MDS—The Past 40 Years. A Look at the Emerging Awareness and Classification of Myelodysplastic Syndromes.

    ... two conditions chronic myelomonocytic leukemia CMML) and refractory anemia with excess blasts (RAEB) that could be ...

    Page last updated 10/19/2015 - 2:29pm.

  7. 2014 Bone Marrow Failure Disease Symposia - Penn State College of Medicine

    ... : A new and effective Treatment option for patients with Refractory Aplastic Anemia who lack HLA matched donors ...

    Page last updated 10/29/2014 - 3:39pm.

  8. Azacitidine in Patients Undergoing Matched Unrelated Stem Cell Transplantation

    ... 2nd or greater complete remission, partial remission, or refractory relapse Chronic lymphocytic leukemia (CLL), Rai Stage 2-4, ...

    Clinical Trial last updated 05/02/2016 - 2:07pm.

  9. HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy (RAFA)

    ... Leukemia (untreated, in remission or with refractory or relapsed disease) Donors will be either human ...

    Clinical Trial last updated 05/09/2016 - 3:19pm.

  10. Ramon Tiu, MD

    ... in cases of MDS with ring sideroblasts, specifically refractory anemia with ring sideroblasts (RARS) and RARS associated with ...

    Bio last updated 03/11/2016 - 1:41pm.